Fastigium biotechnology consists of the co-transfection of mRNA with helper RNAs.

These single-stranded RNA molecules have several hundred nucleotides and are mixed with the mRNA at a molar ratio of less than 1:100.

The translation efficiency of mRNA is enhanced in transfected cells.

This allows the administration to patients of a lower dose of mRNA to achieve the same level of protein expression.

This will decrease the cost of the mRNA product and improve its tolerance by patients.

 Last news


Messenger Biopharma in the newspaper “La Montagne”

posted February 15, 2016

“Messenger Biopharma in the newspaper “La ...Read More